Key Record Dates
ClinicalTrials.gov Identifier: | NCT05158023 |
---|---|
Brief Title: | Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis |
First Submitted : | December 2, 2021 |
First Submitted that Met QC Criteria : | December 2, 2021 |
First Posted : | December 15, 2021 |
Certification/Extension First Submitted : | April 17, 2024 |
Certification/Extension First Posted : | October 18, 2023 |
Last Update Submitted that Met QC Criteria : | April 24, 2024 |
Last Update Posted : | April 26, 2024 |